Erythromycin ethyl succinate
CAS : 1264-62-6
Ref. 3D-FE170906
1g | 75,00 € | ||
2g | 103,00 € | ||
5g | 185,00 € | ||
10g | 231,00 € | ||
25g | 391,00 € |
Informations sur le produit
- (2R,3S,4R,6S)-4-(dimethylamino)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl]oxy}-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-dimethylamino-3-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-1-oxacyclotetradecane-2,10-dione
- 4-(dimethylamino)-2-({14-ethyl-7,12,13-trihydroxy-4-[(5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy]-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl}oxy)-6-methyltetrahydro-2H-pyran-3-yl ethyl butanedioate (non-preferred name)
- 4-Ethoxy-4-Oxo-Butanoate
- Anamycin
- Arpimycin
- Durapaediat
- E-Mycin e
- Eritrocina
- EryPed
- Voir d'autres synonymes
- Eryliquid
- Erythro ES
- Erythro-Holz
- Erythrocin ethyl succinate
- Erythromycin Ethly Succinate.
- Erythromycin Ethyl Succinate
- Erythromycin Ethylsuccinate
- Erythromycin, 2′-(ethyl butanedioate)
- Erythromycin, 2′-(ethyl succinate)
- Erythromycin, mono(ethyl succinate) (ester)
- Erythroped
- Esinol
- Evesin
- Monomycin
- Oxacyclotetradecane, erythromycin deriv.
- Paediathrocin
- Pediamycin
- Refkas
- Sigapedil
- Succinic acid, ethyl ester, monoester with erythromycin
- Wyamycin E
Erythromycin ethyl succinate is an ester prodrug that is formed by the reaction of erythromycin and ethylsuccinic acid. It has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis. Erythromycin ethyl succinate is also active against Haemophilus influenzae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila, Helicobacter pylori, Leptospira interrogans, Bordetella pertussis, Rickettsia rickettsii, Borrelia burgdorferi, Coxiella burnetii, and Mycoplasma pneumoniae. Erythromycin ethyl succinate has been shown to be effective in treating streptococcal pharyngitis and tissue infections.
Propriétés chimiques
Question d’ordre technique sur : 3D-FE170906 Erythromycin ethyl succinate
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages